Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Maleic Acid | HCID 444266 | — |
| Reactant | HCID 11629090 | HCID 11629090 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 86619555 | HCID 86619555 | — |
Reaction Steps
1.0 g (1.39 mmol) (R)-1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate are dissolved in 10 ml of ethanol at ambient temperature and combined with 322 mg (2.78 mmol) maleic acid. The mixture is heated to 70° C., during which time a white precipitate is formed. The suspension is cooled to ambient temperature over 8 hours and filtered at 5° C. The isolated crystals are dried for 12 hours at 50° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07638625B2 |
|---|
| Source dataset | uspto-grants-2009_12 |
|---|
| ORD ID | ord-79eea5e153304be7b638b5bd7f33b3b0 |
|---|
| Source note | uspto-grants-2009_12 |
|---|